# Safety and Efficacy of the HighLife Transcatherter Mitral Valve Replacement System in Patients With Moderate-severe or Severe Mitral Regurgitation in China

Study · id `cardio:ct-nct05610566` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05610566](<https://clinicaltrials.gov/study/NCT05610566>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05610566

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 110 participants.

## Technical summary

Registry record NCT05610566. Allocation not applicable; no masking; primary purpose treatment. Start 2022-07-06 (actual); primary completion 2025-07-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 110 participants (planned count; ClinicalTrials.gov record NCT05610566, source copy `cardio:ctgov-nct05610566-2022-11-09`, retrieved 2026-10-26)
- Started: 2022-07-06 (actual) (ClinicalTrials.gov record NCT05610566, source copy `cardio:ctgov-nct05610566-2022-11-09`, retrieved 2026-10-26)
- Primary completion: 2025-07-06 (anticipated) (ClinicalTrials.gov record NCT05610566, source copy `cardio:ctgov-nct05610566-2022-11-09`, retrieved 2026-10-26)
- Completion: 2029-07-06 (anticipated) (ClinicalTrials.gov record NCT05610566, source copy `cardio:ctgov-nct05610566-2022-11-09`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05610566, source copy `cardio:ctgov-nct05610566-2022-11-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05610566-2022-11-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Efficacy of the HighLife Transcatherter Mitral Valve Replacement System in Patients With Moderate-severe or Severe Mitral Regurgitation in China
- Condition: Mitral Regurgitation
- Intervention (Device): the HighLife Trans-Septal Transcatheter Mitral Valve Replacement System
- Lead sponsor: Peijia Medical Technology (Suzhou) Co., Ltd.
- Lead sponsor class: INDUSTRY
- Collaborator: West China Hospital
- Collaborator class: OTHER
- Collaborator: Second Affiliated Hospital, Zhejiang University, School of Medicine
- Collaborator class: OTHER
- Collaborator: The Second Affiliated Hospital of Harbin Medical University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Mitral regurgitation (`cardio:mitral-regurgitation`)
- Registry lists this organization as the lead sponsor: Peijia Medical Technology (Suzhou) Co., Ltd. (`cardio:org-peijia-medical-technology-suzhou-co-ltd`)
- Registry lists this organization as a collaborator: West China Hospital (`cardio:org-west-china-hospital`)
- Registry lists this organization as a collaborator: Second Affiliated Hospital, Zhejiang University, School of Medicine (`cardio:org-second-affiliated-hospital-zhejiang-university-school-of-bfd3ac`)
- Registry lists this organization as a collaborator: The Second Affiliated Hospital of Harbin Medical University (`cardio:org-the-second-affiliated-hospital-of-harbin-medical-university`)

## Provenance

Content hash: f5f0fc1a3631da473f17648a01e04974928cbbc76aa7e895d94c56c17d883769
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
